aSection of Infectious Diseases, Boston University bRagon Institute of MGH, MIT, and Harvard, Massachusetts General Hospital, Boston cDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts dAIDS and Cancer Virus Program, Science Applications International Corporation-Frederick, National Cancer Institute, Frederick, Maryland eDivision of Infectious Diseases, Massachusetts General Hospital, Boston fDivision of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA gHeinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany. *Rachel P. Simmons and Eileen P. Scully contributed equally to the writing of the article.
AIDS. 2013 Oct 23;27(16):2505-17. doi: 10.1097/01.aids.0000432455.06476.bc.
To study the cytokine/chemokine profiles in response to HIV-1 viremia, and elucidate the pathways leading to HIV-1-induced inflammation.
DESIGN/METHODS: Plasma levels of 19 cytokines in individuals with early HIV-1 infection and individuals undergoing treatment interruptions were evaluated via multiplex assay. To investigate the cellular sources of relevant cytokines, sorted cells from HIV-1 infected individuals were assessed for mRNA expression. Relevant signaling pathways were assessed by comparing cytokine production patterns of peripheral blood mononuclear cells stimulated with intact HIV-1 or specific Toll-like receptor (TLR) stimulants with and without a TLR7/9 antagonist.
IP-10 plasma concentration was most significantly associated with HIV-1 viral load and was the most significant contributor in a multivariate model. IP-10 mRNA was highly expressed in monocytes and mDCs and these cells were the dominant producers after in-vitro stimulation with TLR7/8 ligands (CL097 and ssRNAGag1166), AT-2 HIV-1, and HIV-1NL43 virus. Partial least square discriminant analysis of culture supernatants revealed distinct cytokine/chemokine secretion profiles associated with intact viruses compared with TLR7/8 ligands alone, with IP-10 production linked to the former. A TLR7/9 antagonist blocked IP-10 production following whole virus stimulation, suggesting the involvement of TLR7/9 in the recognition of HIV-1 by these cells.
Monocytes and mDCs produce significant amounts of IP-10 in response to HIV-1 viremia and after in-vitro stimulation with HIV-1. Stimulation with HIV-1-derived TLR7/8-ligands versus HIV-1 resulted in distinct cytokine/chemokine profiles, indicating additional pathways other than TLR7/8 that lead to the activation of innate immune cells by HIV-1.
研究细胞因子/趋化因子谱对 HIV-1 病毒血症的反应,并阐明导致 HIV-1 诱导炎症的途径。
设计/方法:通过多重分析评估早期 HIV-1 感染个体和接受治疗中断个体的血浆中 19 种细胞因子的水平。为了研究相关细胞因子的细胞来源,评估了从 HIV-1 感染个体中分离的细胞的 mRNA 表达。通过比较用完整 HIV-1 或特定 Toll 样受体 (TLR) 激动剂刺激的外周血单核细胞与 TLR7/9 拮抗剂存在和不存在时的细胞因子产生模式来评估相关信号通路。
IP-10 血浆浓度与 HIV-1 病毒载量最显著相关,并且在多变量模型中是最重要的贡献者。IP-10 mRNA 在单核细胞和 mDC 中高度表达,这些细胞在体外用 TLR7/8 配体 (CL097 和 ssRNAGag1166)、AT-2 HIV-1 和 HIV-1NL43 病毒刺激后是主要的产生者。培养上清液的偏最小二乘判别分析显示,与单独 TLR7/8 配体相比,与完整病毒相关的细胞因子/趋化因子分泌谱不同,与前者相关的是 IP-10 的产生。TLR7/9 拮抗剂阻断了整个病毒刺激后的 IP-10 产生,表明 TLR7/9 参与了这些细胞对 HIV-1 的识别。
单核细胞和 mDC 在 HIV-1 病毒血症和体外用 HIV-1 刺激后产生大量的 IP-10。用 HIV-1 衍生的 TLR7/8 配体刺激与用 HIV-1 刺激相比,导致细胞因子/趋化因子谱不同,表明除 TLR7/8 以外的其他途径可导致 HIV-1 激活固有免疫细胞。